Triple‐negative breast cancer (TNBC) is a specific subtype of breast cancer characterized by the absence of three key receptors, including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER‐2). This evidence concerns the gene ERBB2 and breast carcinoma.